Senior insider sale
LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$1.25M
5K shares
What this filing means
ARYEH JASON plans to sell 5K shares of LIGAND PHARMACEUTICALS INC valued at approximately $1.25M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/10/2026ACC: 0001949846-26-000371
5K
Shares to sell
$1.25M
Approx. market value
5K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Open Market Purchases
Cash
4/19/2005
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/19/2005 | Open Market Purchases Cash | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
5K
Market value
$1.25M
6/10/2026
Total
Units
5K
Value
$1.25M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/10/2026 | 5K | $1.25M | Nasdaq | Planned |
| Total | 5K | $1.25M | ||